{"entity":{"type":"insider","cik":"0001283304","url":"/insider/0001283304","json_url":"/insider/0001283304.json","name":"XANTHOPOULOS KLEANTHIS G","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":206,"n_filings":43,"first":"2005-06-23","last":"2016-08-22","span_basis":"filed_date"},"name_variants":[{"name":"XANTHOPOULOS KLEANTHIS G","source":"filing","n_filings":43,"first_seen":"2005-06-23","last_seen":"2016-08-22"}],"transactions":[{"id":3179174,"accession":"0001587221-16-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001587221-16-000005","line_url":"/filing/0001587221-16-000005#line-1","is_derivative":false,"issuer_cik":"0001283304","issuer_name":"Zosano Pharma Corp","issuer_ticker":"ZSAN","issuer_name_source":null,"issuer_url":"/issuer/0001283304","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15920.0,"shares_display":"15,920","price_per_share":1.32,"price_display":"1.32","price_state":"stated","total_value":21014.4,"total_display":"21,014.40","total_whole":"21,014","shares_owned_after":21920.0,"shares_owned_after_display":"21,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-19","filed_date":"2016-08-22","scope":"insider"},{"id":8459828,"accession":"0001209191-15-035362","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-15-035362","line_url":"/filing/0001209191-15-035362#line-6","is_derivative":false,"issuer_cik":"0001283304","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001283304","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":17.733,"price_display":"17.73","price_state":"stated","total_value":1063980.0,"total_display":"1,063,980.00","total_whole":"1,063,980","shares_owned_after":3705.0,"shares_owned_after_display":"3,705","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-21","filed_date":"2015-04-21","scope":"insider"},{"id":8459820,"accession":"0001209191-15-035362","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-035362","line_url":"/filing/0001209191-15-035362#line-4","is_derivative":false,"issuer_cik":"0001283304","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001283304","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":66071.0,"shares_display":"66,071","price_per_share":16.8533,"price_display":"16.85","price_state":"stated","total_value":1113514.3843,"total_display":"1,113,514.38","total_whole":"1,113,514","shares_owned_after":3705.0,"shares_owned_after_display":"3,705","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-20","filed_date":"2015-04-21","scope":"insider"},{"id":8459812,"accession":"0001209191-15-035362","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-035362","line_url":"/filing/0001209191-15-035362#line-2","is_derivative":false,"issuer_cik":"0001283304","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001283304","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":73929.0,"shares_display":"73,929","price_per_share":16.9352,"price_display":"16.94","price_state":"stated","total_value":1252002.4008,"total_display":"1,252,002.40","total_whole":"1,252,002","shares_owned_after":3705.0,"shares_owned_after_display":"3,705","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-17","filed_date":"2015-04-21","scope":"insider"},{"id":8081386,"accession":"0001209191-15-023195","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-023195","line_url":"/filing/0001209191-15-023195","is_derivative":false,"issuer_cik":"0001283304","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001283304","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":89230.0,"shares_display":"89,230","price_per_share":20.262945330045948,"price_display":"20.26","price_state":"stated","total_value":1808062.6118,"total_display":"1,808,062.61","total_whole":"1,808,063","shares_owned_after":26082.0,"shares_owned_after_display":"26,082","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-05","filed_date":"2015-03-05","scope":"insider","n_lines":2},{"id":8773693,"accession":"0001209191-15-021532","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-021532","line_url":"/filing/0001209191-15-021532#line-2","is_derivative":false,"issuer_cik":"0001283304","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001283304","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70.0,"shares_display":"70","price_per_share":19.5,"price_display":"19.50","price_state":"stated","total_value":1365.0,"total_display":"1,365.00","total_whole":"1,365","shares_owned_after":2466.0,"shares_owned_after_display":"2,466","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-27","filed_date":"2015-03-03","scope":"insider"},{"id":8407267,"accession":"0001209191-15-009000","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-009000","line_url":"/filing/0001209191-15-009000#line-4","is_derivative":false,"issuer_cik":"0001283304","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001283304","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":19.7667,"price_display":"19.77","price_state":"stated","total_value":47440.08,"total_display":"47,440.08","total_whole":"47,440","shares_owned_after":2466.0,"shares_owned_after_display":"2,466","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-02","filed_date":"2015-02-03","scope":"insider"},{"id":8407260,"accession":"0001209191-15-009000","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-009000","line_url":"/filing/0001209191-15-009000#line-2","is_derivative":false,"issuer_cik":"0001283304","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001283304","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3300.0,"shares_display":"3,300","price_per_share":19.5004,"price_display":"19.50","price_state":"stated","total_value":64351.32,"total_display":"64,351.32","total_whole":"64,351","shares_owned_after":2466.0,"shares_owned_after_display":"2,466","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-30","filed_date":"2015-02-03","scope":"insider"},{"id":8210488,"accession":"0001209191-15-007971","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-15-007971","line_url":"/filing/0001209191-15-007971","is_derivative":false,"issuer_cik":"0001283304","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001283304","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":18.0439062,"price_display":"18.04","price_state":"stated","total_value":1082634.372,"total_display":"1,082,634.37","total_whole":"1,082,634","shares_owned_after":28693.0,"shares_owned_after_display":"28,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-29","filed_date":"2015-01-30","scope":"insider","n_lines":2},{"id":8210473,"accession":"0001209191-15-007971","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-007971","line_url":"/filing/0001209191-15-007971","is_derivative":false,"issuer_cik":"0001283304","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001283304","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":85000.0,"shares_display":"85,000","price_per_share":18.076649409411765,"price_display":"18.08","price_state":"stated","total_value":1536515.1998,"total_display":"1,536,515.20","total_whole":"1,536,515","shares_owned_after":15455.0,"shares_owned_after_display":"15,455","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-28","filed_date":"2015-01-30","scope":"insider","n_lines":2},{"id":6848333,"accession":"0001209191-14-065583","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-065583","line_url":"/filing/0001209191-14-065583","is_derivative":false,"issuer_cik":"0001283304","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001283304","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3505.0,"shares_display":"3,505","price_per_share":19.35061340941512,"price_display":"19.35","price_state":"stated","total_value":67823.9,"total_display":"67,823.90","total_whole":"67,824","shares_owned_after":2566.0,"shares_owned_after_display":"2,566","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-29","filed_date":"2014-10-31","scope":"insider","n_lines":3},{"id":6322917,"accession":"0001209191-14-064146","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-064146","line_url":"/filing/0001209191-14-064146#line-4","is_derivative":false,"issuer_cik":"0001283304","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001283304","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":2100.0,"total_display":"2,100.00","total_whole":"2,100","shares_owned_after":2466.0,"shares_owned_after_display":"2,466","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-20","filed_date":"2014-10-21","scope":"insider"},{"id":6322914,"accession":"0001209191-14-064146","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-064146","line_url":"/filing/0001209191-14-064146#line-2","is_derivative":false,"issuer_cik":"0001283304","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001283304","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":7.04,"price_display":"7.04","price_state":"stated","total_value":2816.0,"total_display":"2,816.00","total_whole":"2,816","shares_owned_after":2466.0,"shares_owned_after_display":"2,466","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-17","filed_date":"2014-10-21","scope":"insider"},{"id":6448272,"accession":"0001209191-14-063130","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-063130","line_url":"/filing/0001209191-14-063130#line-4","is_derivative":false,"issuer_cik":"0001283304","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001283304","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":2800.0,"total_display":"2,800.00","total_whole":"2,800","shares_owned_after":2466.0,"shares_owned_after_display":"2,466","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-14","filed_date":"2014-10-14","scope":"insider"},{"id":6448266,"accession":"0001209191-14-063130","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-063130","line_url":"/filing/0001209191-14-063130#line-2","is_derivative":false,"issuer_cik":"0001283304","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001283304","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":105.0,"shares_display":"105","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":735.0,"total_display":"735.00","total_whole":"735","shares_owned_after":2466.0,"shares_owned_after_display":"2,466","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-09","filed_date":"2014-10-14","scope":"insider"},{"id":6738222,"accession":"0001209191-14-061263","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-061263","line_url":"/filing/0001209191-14-061263#line-2","is_derivative":false,"issuer_cik":"0001283304","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001283304","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2300.0,"shares_display":"2,300","price_per_share":7.0163,"price_display":"7.02","price_state":"stated","total_value":16137.49,"total_display":"16,137.49","total_whole":"16,137","shares_owned_after":2466.0,"shares_owned_after_display":"2,466","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-30","filed_date":"2014-10-02","scope":"insider"},{"id":7034977,"accession":"0001209191-14-055078","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-055078","line_url":"/filing/0001209191-14-055078#line-2","is_derivative":false,"issuer_cik":"0001283304","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001283304","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3505.0,"shares_display":"3,505","price_per_share":7.0626,"price_display":"7.06","price_state":"stated","total_value":24754.413,"total_display":"24,754.41","total_whole":"24,754","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-28","filed_date":"2014-08-29","scope":"insider"},{"id":6876471,"accession":"0001209191-14-051215","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-051215","line_url":"/filing/0001209191-14-051215#line-2","is_derivative":false,"issuer_cik":"0001283304","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001283304","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3505.0,"shares_display":"3,505","price_per_share":7.0583,"price_display":"7.06","price_state":"stated","total_value":24739.3415,"total_display":"24,739.34","total_whole":"24,739","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-05","filed_date":"2014-08-07","scope":"insider"},{"id":6845821,"accession":"0001209191-14-045260","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-045260","line_url":"/filing/0001209191-14-045260#line-2","is_derivative":false,"issuer_cik":"0001283304","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001283304","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3505.0,"shares_display":"3,505","price_per_share":8.11,"price_display":"8.11","price_state":"stated","total_value":28425.55,"total_display":"28,425.55","total_whole":"28,426","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-01","filed_date":"2014-07-02","scope":"insider"},{"id":6678223,"accession":"0001209191-14-039996","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-039996","line_url":"/filing/0001209191-14-039996#line-2","is_derivative":false,"issuer_cik":"0001283304","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001283304","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3505.0,"shares_display":"3,505","price_per_share":7.1376,"price_display":"7.14","price_state":"stated","total_value":25017.288,"total_display":"25,017.29","total_whole":"25,017","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-09","filed_date":"2014-06-09","scope":"insider"},{"id":6414237,"accession":"0001209191-14-037812","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-14-037812","line_url":"/filing/0001209191-14-037812#line-6","is_derivative":false,"issuer_cik":"0001283304","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001283304","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":887.0,"shares_display":"887","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":6209.0,"total_display":"6,209.00","total_whole":"6,209","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-29","filed_date":"2014-05-29","scope":"insider"},{"id":6414233,"accession":"0001209191-14-037812","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-037812","line_url":"/filing/0001209191-14-037812#line-4","is_derivative":false,"issuer_cik":"0001283304","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001283304","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":875.0,"shares_display":"875","price_per_share":7.0011,"price_display":"7.00","price_state":"stated","total_value":6125.9625,"total_display":"6,125.96","total_whole":"6,126","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-28","filed_date":"2014-05-29","scope":"insider"},{"id":6414227,"accession":"0001209191-14-037812","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-037812","line_url":"/filing/0001209191-14-037812#line-2","is_derivative":false,"issuer_cik":"0001283304","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001283304","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1743.0,"shares_display":"1,743","price_per_share":7.0011,"price_display":"7.00","price_state":"stated","total_value":12202.9173,"total_display":"12,202.92","total_whole":"12,203","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-27","filed_date":"2014-05-29","scope":"insider"},{"id":7088790,"accession":"0001209191-14-018179","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-018179","line_url":"/filing/0001209191-14-018179#line-2","is_derivative":false,"issuer_cik":"0001283304","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001283304","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3505.0,"shares_display":"3,505","price_per_share":11.349,"price_display":"11.35","price_state":"stated","total_value":39778.245,"total_display":"39,778.24","total_whole":"39,778","shares_owned_after":80216.0,"shares_owned_after_display":"80,216","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-03-06","filed_date":"2014-03-07","scope":"insider"},{"id":6471499,"accession":"0001209191-14-026601","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-026601","line_url":"/filing/0001209191-14-026601#line-2","is_derivative":false,"issuer_cik":"0001283304","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001283304","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3505.0,"shares_display":"3,505","price_per_share":7.5957,"price_display":"7.60","price_state":"stated","total_value":26622.9285,"total_display":"26,622.93","total_whole":"26,623","shares_owned_after":80216.0,"shares_owned_after_display":"80,216","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-03-06","filed_date":"2014-04-09","scope":"insider"},{"id":7032494,"accession":"0001209191-14-008312","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-008312","line_url":"/filing/0001209191-14-008312#line-2","is_derivative":false,"issuer_cik":"0001283304","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001283304","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3505.0,"shares_display":"3,505","price_per_share":8.3987,"price_display":"8.40","price_state":"stated","total_value":29437.4435,"total_display":"29,437.44","total_whole":"29,437","shares_owned_after":80216.0,"shares_owned_after_display":"80,216","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-02-05","filed_date":"2014-02-07","scope":"insider"},{"id":6311401,"accession":"0001209191-14-000372","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-000372","line_url":"/filing/0001209191-14-000372#line-2","is_derivative":false,"issuer_cik":"0001283304","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001283304","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3505.0,"shares_display":"3,505","price_per_share":7.2492,"price_display":"7.25","price_state":"stated","total_value":25408.446,"total_display":"25,408.45","total_whole":"25,408","shares_owned_after":80216.0,"shares_owned_after_display":"80,216","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-01-02","filed_date":"2014-01-02","scope":"insider"},{"id":5507932,"accession":"0001181431-13-064642","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-064642","line_url":"/filing/0001181431-13-064642#line-1","is_derivative":false,"issuer_cik":"0001017491","issuer_name":"APRICUS BIOSCIENCES, INC.","issuer_ticker":"APRI","issuer_name_source":null,"issuer_url":"/issuer/0001017491","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17184.0,"shares_display":"17,184","price_per_share":2.55,"price_display":"2.55","price_state":"stated","total_value":43819.2,"total_display":"43,819.20","total_whole":"43,819","shares_owned_after":55735.0,"shares_owned_after_display":"55,735","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-12-26","filed_date":"2013-12-27","scope":"insider"},{"id":4549910,"accession":"0001181431-13-036351","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-036351","line_url":"/filing/0001181431-13-036351#line-1","is_derivative":false,"issuer_cik":"0001017491","issuer_name":"APRICUS BIOSCIENCES, INC.","issuer_ticker":"APRI","issuer_name_source":null,"issuer_url":"/issuer/0001017491","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2864.0,"shares_display":"2,864","price_per_share":2.52,"price_display":"2.52","price_state":"stated","total_value":7217.28,"total_display":"7,217.28","total_whole":"7,217","shares_owned_after":72919.0,"shares_owned_after_display":"72,919","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-06-21","filed_date":"2013-06-21","scope":"insider"},{"id":5329525,"accession":"0001181431-13-030396","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-030396","line_url":"/filing/0001181431-13-030396#line-1","is_derivative":false,"issuer_cik":"0001017491","issuer_name":"APRICUS BIOSCIENCES, INC.","issuer_ticker":"APRI","issuer_name_source":null,"issuer_url":"/issuer/0001017491","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2864.0,"shares_display":"2,864","price_per_share":3.3564,"price_display":"3.36","price_state":"stated","total_value":9612.7296,"total_display":"9,612.73","total_whole":"9,613","shares_owned_after":75783.0,"shares_owned_after_display":"75,783","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-05-21","filed_date":"2013-05-23","scope":"insider"},{"id":5203415,"accession":"0001181431-13-023075","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-023075","line_url":"/filing/0001181431-13-023075#line-1","is_derivative":false,"issuer_cik":"0001017491","issuer_name":"APRICUS BIOSCIENCES, INC.","issuer_ticker":"APRI","issuer_name_source":null,"issuer_url":"/issuer/0001017491","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2864.0,"shares_display":"2,864","price_per_share":2.627,"price_display":"2.63","price_state":"stated","total_value":7523.728,"total_display":"7,523.73","total_whole":"7,524","shares_owned_after":78647.0,"shares_owned_after_display":"78,647","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-04-22","filed_date":"2013-04-22","scope":"insider"},{"id":4625151,"accession":"0001181431-13-018345","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-018345","line_url":"/filing/0001181431-13-018345#line-1","is_derivative":false,"issuer_cik":"0001017491","issuer_name":"APRICUS BIOSCIENCES, INC.","issuer_ticker":"APRI","issuer_name_source":null,"issuer_url":"/issuer/0001017491","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2864.0,"shares_display":"2,864","price_per_share":2.5,"price_display":"2.50","price_state":"stated","total_value":7160.0,"total_display":"7,160.00","total_whole":"7,160","shares_owned_after":81511.0,"shares_owned_after_display":"81,511","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-03-21","filed_date":"2013-03-21","scope":"insider"},{"id":2121162,"accession":"0001144204-12-054091","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-12-054091","line_url":"/filing/0001144204-12-054091#line-1","is_derivative":false,"issuer_cik":"0001017491","issuer_name":"APRICUS BIOSCIENCES, INC.","issuer_ticker":"APRI","issuer_name_source":null,"issuer_url":"/issuer/0001017491","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3125.0,"shares_display":"3,125","price_per_share":3.2506,"price_display":"3.25","price_state":"stated","total_value":10158.125,"total_display":"10,158.12","total_whole":"10,158","shares_owned_after":84375.0,"shares_owned_after_display":"84,375","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-09-28","filed_date":"2012-10-01","scope":"insider"},{"id":2144996,"accession":"0001144204-12-046893","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-12-046893","line_url":"/filing/0001144204-12-046893#line-1","is_derivative":false,"issuer_cik":"0001017491","issuer_name":"APRICUS BIOSCIENCES, INC.","issuer_ticker":"APRI","issuer_name_source":null,"issuer_url":"/issuer/0001017491","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":3.0147,"price_display":"3.01","price_state":"stated","total_value":37683.75,"total_display":"37,683.75","total_whole":"37,684","shares_owned_after":87500.0,"shares_owned_after_display":"87,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-15","filed_date":"2012-08-17","scope":"insider"},{"id":8238261,"accession":"0001209191-07-048895","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-07-048895","line_url":"/filing/0001209191-07-048895#line-1","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6500.0,"shares_display":"6,500","price_per_share":2.1473,"price_display":"2.15","price_state":"stated","total_value":13957.45,"total_display":"13,957.45","total_whole":"13,957","shares_owned_after":177144.0,"shares_owned_after_display":"177,144","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-08-16","filed_date":"2007-08-16","scope":"insider"},{"id":4967943,"accession":"0001209191-06-059639","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-06-059639","line_url":"/filing/0001209191-06-059639#line-1","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":500.0,"total_display":"500.00","total_whole":"500","shares_owned_after":175644.0,"shares_owned_after_display":"175,644","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-11-14","filed_date":"2006-11-15","scope":"insider"},{"id":3845802,"accession":"0001209191-06-037512","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-06-037512","line_url":"/filing/0001209191-06-037512","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":6.999777777777778,"price_display":"7.00","price_state":"stated","total_value":62998.0,"total_display":"62,998.00","total_whole":"62,998","shares_owned_after":7089.0,"shares_owned_after_display":"7,089","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-06-19","filed_date":"2006-06-20","scope":"insider","n_lines":6},{"id":5466133,"accession":"0001209191-06-030802","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-06-030802","line_url":"/filing/0001209191-06-030802#line-7","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2176.0,"shares_display":"2,176","price_per_share":10.52,"price_display":"10.52","price_state":"stated","total_value":22891.52,"total_display":"22,891.52","total_whole":"22,892","shares_owned_after":181568.0,"shares_owned_after_display":"181,568","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-05-15","filed_date":"2006-05-17","scope":"insider"},{"id":5466131,"accession":"0001209191-06-030802","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-06-030802","line_url":"/filing/0001209191-06-030802#line-6","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":10.48,"price_display":"10.48","price_state":"stated","total_value":8384.0,"total_display":"8,384.00","total_whole":"8,384","shares_owned_after":180768.0,"shares_owned_after_display":"180,768","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-05-15","filed_date":"2006-05-17","scope":"insider"},{"id":5466129,"accession":"0001209191-06-030802","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-06-030802","line_url":"/filing/0001209191-06-030802#line-5","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":"0001283304","owner_name":"XANTHOPOULOS KLEANTHIS G","owner_display_name":"XANTHOPOULOS KLEANTHIS G","owner_url":"/insider/0001283304","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":10.51,"price_display":"10.51","price_state":"stated","total_value":7357.0,"total_display":"7,357.00","total_whole":"7,357","shares_owned_after":180068.0,"shares_owned_after_display":"180,068","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-05-15","filed_date":"2006-05-17","scope":"insider"}],"collapsed":true,"next_cursor":"2006-05-15|5466129","ledger_fault":false,"count":{"value":206,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":204,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":206},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001587221","name":"Zosano Pharma Corp","url":"/issuer/0001587221","role":"Director","n_filings":1,"first_seen":"2016-08-22","last_seen":"2016-08-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001505512","name":"Regulus Therapeutics Inc.","url":"/issuer/0001505512","role":"Director, Officer (President and CEO)","n_filings":18,"first_seen":"2014-01-02","last_seen":"2015-04-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001017491","name":"APRICUS BIOSCIENCES, INC.","url":"/issuer/0001017491","role":"Director","n_filings":7,"first_seen":"2012-08-17","last_seen":"2013-12-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001128495","name":"ANADYS PHARMACEUTICALS INC","url":"/issuer/0001128495","role":"Director, Officer (CEO and President)","n_filings":17,"first_seen":"2005-06-23","last_seen":"2007-08-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001283304","retrieved_at":"2026-08-22T12:01:12+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}